Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 23Recruiting 11Active not recruiting 8Terminated 6Unknown 5No longer available 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Pheochromocytoma 4Neuroendocrine Tumors 4Pituitary Neoplasms 3Paraganglioma 3Multiple Endocrine Neoplasia Type 1 3Hyperaldosteronism 2Epilepsy 2Diabetes Mellitus 2Adrenal Gland Neoplasms 2von Willebrand Disease, Type 3 1beta-Thalassemia 1Xanthomatosis, Cerebrotendinous 1X-Linked Combined Immunodeficiency Diseases 1Wolman Disease 1Waardenburg syndrome type 2A 1Waardenburg syndrome type 2 1Waardenburg Syndrome 1VLCAD deficiency 1Usher syndrome, type 1F 1Usher syndrome, type 1C 1Usher syndrome, type 1B 1Tyrosinemias 1Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Trifunctional Protein Deficiency With Myopathy And Neuropathy 1Thyroid Neoplasms 1Thyroid Dyshormonogenesis 6 1Thyroid Dyshormonogenesis 5 1Thyroid Dyshormonogenesis 3 1Thyroid Dyshormonogenesis 2A 1

Interventions

PM 01183 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Adenoma, Islet Cell × Endocrine × Clear all
NCT07121478 2025-10-01

Patients With High-grade Pancreatic Neuroendocrine Tumors

National Cancer Center, Korea

Phase 2 Enrolling by invitation
46 enrolled
EndocrineNET

Adenoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡